Field
MASLD
Metabolic dysfunction-associated steatotic liver disease.
Our MASLD (formerly NAFLD/NASH) programme has convened hepatologists, translational scientists and clinical developers working on this rapidly-evolving therapeutic area.
No active MASLD event is scheduled. Related translational content runs inside our Clinical Trials and Precision Medicine meetings.
Where to find MASLD content today
Register interest
Hear first when MASLD returns
Tell us you're interested and we'll be in touch when a new edition, webinar or report is planned in this field.